AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12029205 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart-median ratio of 123I-MIBG uptake
Number of subjects: 58
Study 10079452 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical anesthesia (bupivacaine 0.75%)
Number of subjects: 245
Study 10079452 — intervention group
Group type: COMPARATOR
Intervention: Paraoocular anesthesia
Number of subjects: 245
Study 7573090 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg hs (average dose 29.5 mg)
Number of subjects: 94
Study 7573090 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 2076392 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (80 mg per day)
Number of subjects: 425
Study 2076392 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 425
Study 6769452 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbonated bupivacaine
Number of subjects: 40
Study 6769452 — intervention group
Group type: COMPARATOR
Intervention: Bupivacaine hydrochloride
Number of subjects: 40
Study 30601990 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical headgear (CH) treatment in early group (EG)
Number of subjects: 67
Study 30601990 — intervention group
Group type: COMPARATOR
Intervention: Cervical headgear (CH) treatment in late group (LG)
Number of subjects: 67
Study 28002391 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formula (bovine milk-derived oligosaccharides and Bifidobacterium animalis ssp lactis)
Number of subjects: 413
Study 28002391 — intervention group
Group type: COMPARATOR
Intervention: Control formula (without bovine milk-derived oligosaccharides and B. lactis)
Number of subjects: 413
Study 28002391 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formula
Number of subjects: 413
Study 25823975 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg
Number of subjects: 143
Study 25823975 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg
Number of subjects: 143
Study 25823975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 143
Study 25823975 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg with enzyme‐inducing AEDs
Number of subjects: 143
Study 25823975 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg with enzyme‐inducing AEDs
Number of subjects: 143
Study 25823975 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 8 mg with non‐inducing AEDs
Number of subjects: 143
Study 25823975 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel 12 mg with non‐inducing AEDs
Number of subjects: 143
Study 25823975 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel during extension (Weeks 1‐52)
Number of subjects: 143
Study 25823975 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 143
Study 22752539 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy conservation programme
Number of subjects: 23
Study 22752539 — intervention group
Group type: COMPARATOR
Intervention: Peer support group
Number of subjects: 23
Study 21063868 — intervention group
Group type: EXPERIMENTAL
Intervention: Red Bull® Energy Drink (250 ml)
Number of subjects: 24
Study 21063868 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21063868 — intervention group
Group type: COMPARATOR
Intervention: Uninterrupted driving
Number of subjects: 24
Study 19728932 — intervention group
Group type: EXPERIMENTAL
Intervention: Photodynamic therapy
Number of subjects: 75
Study 17920499 — intervention group
Group type: EXPERIMENTAL
Intervention: Facemask with expansion (FMEXP)
Number of subjects: 28
Study 17920499 — intervention group
Group type: EXPERIMENTAL
Intervention: Facemask only (FM)
Number of subjects: 28
Study 17920499 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 15291290 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife management
Number of subjects: 1352
Study 15291290 — intervention group
Group type: COMPARATOR
Intervention: Physician management
Number of subjects: 1352
Study 12785046 — intervention group
Group type: EXPERIMENTAL
Intervention: Residents who wrote down their patients' pain score as a fifth vital sign in the medical record
Number of subjects: 0
Study 12785046 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention group (residents who did not write down pain scores)
Number of subjects: 0
Study 9645979 — intervention group
Group type: EXPERIMENTAL
Intervention: 619C89 (up to 2.5 mg/kg loading plus 1.25 mg/kg/8 h maintenance)
Number of subjects: 48
Study 9645979 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 9645979 — intervention group
Group type: EXPERIMENTAL
Intervention: 619C89 (doses below 2 mg/kg + 1 mg/kg/8 h)
Number of subjects: 48
Study 9645979 — intervention group
Group type: EXPERIMENTAL
Intervention: 619C89 (2 mg/kg/8 h or more)
Number of subjects: 48
Study 9645979 — intervention group
Group type: EXPERIMENTAL
Intervention: 619C89
Number of subjects: 48
Study 7907174 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine and didanosine combination therapy
Number of subjects: 68
Study 2790863 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mM ZnCl2
Number of subjects: 16
Study 2790863 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mM ZnCl2
Number of subjects: 16
Study 2790863 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mM ZnCl2
Number of subjects: 16
Study 2790863 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mM ZnCl2
Number of subjects: 16
Study 2790863 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mM ZnCl2 (in heavy plaque formers)
Number of subjects: 16
Study 2790863 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mM ZnCl2 (in heavy plaque formers)
Number of subjects: 16
Study 2790863 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mM ZnCl2 (on acid production)
Number of subjects: 16
Study 2790863 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mM ZnCl2 (on acid production)
Number of subjects: 16
Study 362874 — intervention group
Group type: EXPERIMENTAL
Intervention: phenylpropanolamine/aromatic oil syrup
Number of subjects: 80
Study 362874 — intervention group
Group type: EXPERIMENTAL
Intervention: phenylpropanolamine syrup
Number of subjects: 80
Study 362874 — intervention group
Group type: EXPERIMENTAL
Intervention: aromatic oil syrup
Number of subjects: 80
Study 362874 — intervention group
Group type: COMPARATOR
Intervention: placebo syrup
Number of subjects: 80
Study 29951911 — intervention group
Group type: EXPERIMENTAL
Intervention: BladderScan® BVI 9400
Number of subjects: 407
Study 29951911 — intervention group
Group type: COMPARATOR
Intervention: Transurethral catheterization
Number of subjects: 407
Study 28969994 — intervention group
Group type: EXPERIMENTAL
Intervention: Static thermal testing using cold stimuli
Number of subjects: 30
Study 28969994 — intervention group
Group type: EXPERIMENTAL
Intervention: Random heat pulses
Number of subjects: 30
Study 28969994 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal summation at the heat pain threshold
Number of subjects: 30
Study 28969994 — intervention group
Group type: EXPERIMENTAL
Intervention: Pressure pain stimuli
Number of subjects: 30
Study 28969994 — intervention group
Group type: EXPERIMENTAL
Intervention: Temporal summation pain score changes using 2 pinprick probes (256 and 512 mN)
Number of subjects: 30
Study 28969994 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed recovery
Number of subjects: 30
Study 26267983 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen 500 mg taken orally 30 minutes before endometrial biopsy
Number of subjects: 80
Study 26267983 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 23201831 — intervention group
Group type: EXPERIMENTAL
Intervention: Processed food pattern (highest tertile)
Number of subjects: 249
Study 23201831 — intervention group
Group type: COMPARATOR
Intervention: Whole food pattern (not explicitly mentioned in outcomes)
Number of subjects: 249
Study 20530522 — intervention group
Group type: EXPERIMENTAL
Intervention: Prasterone (DHEA) 200 mg/day
Number of subjects: 13
Study 20530522 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 18946771 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored intervention employing motivational interviewing and telephone follow‐up
Number of subjects: 543
Study 18946771 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 543
Study 16181530 — intervention group
Group type: EXPERIMENTAL
Intervention: Yufeining pills taken orally for half a year
Number of subjects: 36
Study 16181530 — intervention group
Group type: COMPARATOR
Intervention: Control group (no medicine)
Number of subjects: 36
Study 12708207 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil (0.1 microgram.Kg‐1.min.‐1)
Number of subjects: 60
Study 12708207 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl (1 microgram.Kg‐1) and Midazolam (0.02 mg.Kg‐1)
Number of subjects: 60
Study 12708207 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 60
Study 12708207 — intervention group
Group type: COMPARATOR
Intervention: Fentanyl and Midazolam
Number of subjects: 60
Study 10532439 — intervention group
Group type: EXPERIMENTAL
Intervention: asp+IOL
Number of subjects: 74
Study 10532439 — intervention group
Group type: COMPARATOR
Intervention: IOL-alone
Number of subjects: 74
Study 10532439 — intervention group
Group type: COMPARATOR
Intervention: triple procedure
Number of subjects: 74
Study 8696067 — intervention group
Group type: EXPERIMENTAL
Intervention: High blood pressure prevalence
Number of subjects: 825
Study 8696067 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-insulin dependent diabetes mellitus prevalence
Number of subjects: 825
Study 8696067 — intervention group
Group type: EXPERIMENTAL
Intervention: Dyslipidemia prevalence
Number of subjects: 825
Study 1997425 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunization with Salmonella typhi Ty21a
Number of subjects: 0
Study 1997425 — intervention group
Group type: COMPARATOR
Intervention: Parenteral administration of heat‐killed typhoid vaccine
Number of subjects: 0
Study 6340007 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 0
Study 6340007 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 0
Study 30787659 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice with exercise (BJE, 200ml with ≈ 800mg nitrate and 40 minutes of moderate‐intensity aerobic exercise)
Number of subjects: 14
Study 30787659 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot juice with exercise (BJE)
Number of subjects: 14
Study 30787659 — intervention group
Group type: EXPERIMENTAL
Intervention: Fruit soda with exercise (FSE)
Number of subjects: 14
Study 30787659 — intervention group
Group type: COMPARATOR
Intervention: Control (CON, 200ml of water)
Number of subjects: 14
Study 30787659 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 14
Study 29716912 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity dynamic light (1700 lux)
Number of subjects: 10
Study 29716912 — intervention group
Group type: COMPARATOR
Intervention: Control lighting (300 lux)
Number of subjects: 10
Study 26825564 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal massage
Number of subjects: 60
Study 26825564 — intervention group
Group type: COMPARATOR
Intervention: Control group (no abdominal massage)
Number of subjects: 60
Study 25128877 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense bout of cycling
Number of subjects: 32
Study 25128877 — intervention group
Group type: COMPARATOR
Intervention: Rest (Control)
Number of subjects: 32
Study 22072430 — intervention group
Group type: EXPERIMENTAL
Intervention: Ulimorelin 480 μg/kg
Number of subjects: 236
Study 22072430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 236
Study 20658812 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPES program (1 year of intensive skills training and health management, followed by a 1-year maintenance phase)
Number of subjects: 183
Study 20658812 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 183
Study 18160764 — intervention group
Group type: EXPERIMENTAL
Intervention: Catechin (500 mg: equivalent to 6 or 7 cups of green tea)
Number of subjects: 40
Study 18160764 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 11)
Number of subjects: 40
Study 16968503 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin, amoxicillin, esomeprazole (Group A)
Number of subjects: 300
Study 16968503 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin, metronidazole, esomeprazole (Group B)
Number of subjects: 300
Study 16968503 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin, levofloxacin, esomeprazole (Group C)
Number of subjects: 300
Study 15383130 — intervention group
Group type: EXPERIMENTAL
Intervention: Bipolar I depression patients
Number of subjects: 958
Study 10908914 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CE)
Number of subjects: 90
Study 10908914 — intervention group
Group type: COMPARATOR
Intervention: Best medical care
Number of subjects: 90
Study 8719715 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorion Villus Sampling (CVS)
Number of subjects: 1492
Study 8719715 — intervention group
Group type: COMPARATOR
Intervention: Early Amniocentesis (EA)
Number of subjects: 1492
Study 8719715 — intervention group
Group type: EXPERIMENTAL
Intervention: Chorion Villus Sampling (CVS) and Early Amniocentesis (EA)
Number of subjects: 1492
Study 1348405 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg cetirizine
Number of subjects: 216
Study 1348405 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg cetirizine
Number of subjects: 216
Study 1348405 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 216
Study 3906227 — intervention group
Group type: EXPERIMENTAL
Intervention: Bicarbonate dialysate
Number of subjects: 16
Study 3906227 — intervention group
Group type: COMPARATOR
Intervention: Acetate dialysate
Number of subjects: 16
Study 31690537 — intervention group
Group type: EXPERIMENTAL
Intervention: TN + Nutriluv (multimedia site in diabetes)
Number of subjects: 161
Study 31690537 — intervention group
Group type: COMPARATOR
Intervention: TN (control group)
Number of subjects: 161
Study 31229204 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphedema self-management program including training and a training booklet on exercise, massage, and prevention methods
Number of subjects: 61
Study 31229204 — intervention group
Group type: COMPARATOR
Intervention: Control group (no self-management program)
Number of subjects: 61
Study 31229204 — intervention group
Group type: EXPERIMENTAL
Intervention: Lymphedema self-management program
Number of subjects: 61
Study 27890521 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentives up to $520 for attending sessions and meeting weight loss goals
Number of subjects: 1154
Study 27890521 — intervention group
Group type: COMPARATOR
Intervention: No financial incentives
Number of subjects: 1154
Study 26452540 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon anesthesia
Number of subjects: 190
Study 26452540 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane anesthesia
Number of subjects: 190
Study 23390092 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cell therapy
Number of subjects: 28
Study 23390092 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral blood progenitor cell therapy
Number of subjects: 28
Study 23390092 — intervention group
Group type: COMPARATOR
Intervention: Control treatment
Number of subjects: 28
Study 21393394 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin (unfractionated or low molecular weight [enoxaparin])
Number of subjects: 3994
Study 21393394 — intervention group
Group type: COMPARATOR
Intervention: Fondaparinux
Number of subjects: 3994
Study 21393394 — intervention group
Group type: COMPARATOR
Intervention: Heparin-treated patients (ELISA positive but platelet-activating antibody negative)
Number of subjects: 3994
Study 21393394 — intervention group
Group type: COMPARATOR
Intervention: Heparin-treated antibody-negative control subjects
Number of subjects: 3994
Study 19716489 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine-based postoperative PCA with preoperative anxiolytics prescribed
Number of subjects: 51
Study 19716489 — intervention group
Group type: COMPARATOR
Intervention: Morphine-based postoperative PCA without preoperative anxiolytics prescribed
Number of subjects: 51
Study 19716489 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine-based postoperative PCA
Number of subjects: 51
Study 17705990 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 0
Study 17705990 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone
Number of subjects: 0
Study 17705990 — intervention group
Group type: EXPERIMENTAL
Intervention: Reperfusion
Number of subjects: 0
Study 15281043 — intervention group
Group type: EXPERIMENTAL
Intervention: Yale Physical Activity Survey (YPAS)
Number of subjects: 28
Study 15281043 — intervention group
Group type: COMPARATOR
Intervention: Derived EEPA
Number of subjects: 28
Study 11478826 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral formula supplemented with 22 g/l partially hydrolyzed guar (soluble fiber)
Number of subjects: 25
Study 11478826 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric isonitrogenous control feed without fiber
Number of subjects: 25
Study 10453750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedalling rate of 40 rev.min(‐1)
Number of subjects: 6
Study 10453750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedalling rate of 60 rev.min(‐1)
Number of subjects: 6
Study 10453750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedalling rate of 80 rev.min(‐1)
Number of subjects: 6
Study 10453750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedalling rate of 100 rev.min(‐1)
Number of subjects: 6
Study 10453750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedalling rate of 120 rev.min(‐1)
Number of subjects: 6
Study 10453750 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedalling rate increase from 100 to 120 rev.min(‐1)
Number of subjects: 6
Study 8555550 — intervention group
Group type: COMPARATOR
Intervention: Constant ultrafiltration with constant dialysate Na of 140 mEq/L (Group A)
Number of subjects: 12
Study 8555550 — intervention group
Group type: COMPARATOR
Intervention: Sequentially decreasing ultrafiltration with constant dialysate Na (Group B)
Number of subjects: 12
Study 8555550 — intervention group
Group type: COMPARATOR
Intervention: Sequentially decreasing ultrafiltration with sequentially decreasing dialysate Na from 150 to 140 mEq/L (Group C)
Number of subjects: 12
Study 3310843 — intervention group
Group type: EXPERIMENTAL
Intervention: Baked rice (90 g, raw, cooked for 10 min at 160 degrees C after boiling)
Number of subjects: 14
Study 3310843 — intervention group
Group type: COMPARATOR
Intervention: Boiled rice (90 g, raw, boiled in salted water)
Number of subjects: 14
Study 30817829 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical interventions
Number of subjects: 0
Study 30817829 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological interventions
Number of subjects: 0
Study 30817829 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral interventions
Number of subjects: 0
Study 30817829 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical interventions
Number of subjects: 0
Study 30817829 — intervention group
Group type: COMPARATOR
Intervention: Randomized controlled trials
Number of subjects: 0
Study 28428736 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose supplementation (4 g/kg BM)
Number of subjects: 0
Study 28428736 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose supplementation (4 g/kg BM)
Number of subjects: 0
Study 28428736 — intervention group
Group type: COMPARATOR
Intervention: Baseline (no sugar supplementation)
Number of subjects: 0
Study 25913040 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF + Pantoprazole (PAN) 40 mg
Number of subjects: 20
Study 25913040 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-MPS + Pantoprazole (PAN) 40 mg
Number of subjects: 20
Study 25913040 — intervention group
Group type: EXPERIMENTAL
Intervention: EC-MPS + Pantoprazole (PAN)
Number of subjects: 20
Study 25913040 — intervention group
Group type: EXPERIMENTAL
Intervention: MMF + Pantoprazole (PAN)
Number of subjects: 20
Study 25913040 — intervention group
Group type: COMPARATOR
Intervention: MMF and EC-MPS
Number of subjects: 20
Study 23473652 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD) under dim light conditions (75 lx)
Number of subjects: 38
Study 23473652 — intervention group
Group type: EXPERIMENTAL
Intervention: Tryptophan depletion (TD) under varying light conditions (585 lx and 1530 lx)
Number of subjects: 38
Study 21763475 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical stabilization with plating
Number of subjects: 100
Study 21763475 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 100
Study 19492646 — intervention group
Group type: EXPERIMENTAL
Intervention: platform-enlarged implants
Number of subjects: 60
Study 19492646 — intervention group
Group type: COMPARATOR
Intervention: control implants with an abutment as large as the implant platform
Number of subjects: 60
Study 19492646 — intervention group
Group type: COMPARATOR
Intervention: control implants with a reduced abutment
Number of subjects: 60
Study 19492646 — intervention group
Group type: EXPERIMENTAL
Intervention: submerged implants with an enlarged platform
Number of subjects: 60
Study 17108797 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic taping + physical therapy
Number of subjects: 18
Study 17108797 — intervention group
Group type: COMPARATOR
Intervention: Physical therapy only
Number of subjects: 18
Study 15346082 — intervention group
Group type: EXPERIMENTAL
Intervention: Less Invasive Stabilization System (LISS)
Number of subjects: 32
Study 15346082 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal Femoral Nail
Number of subjects: 32
Study 15346082 — intervention group
Group type: COMPARATOR
Intervention: Plate group (control)
Number of subjects: 32
Study 15346082 — intervention group
Group type: EXPERIMENTAL
Intervention: Nail group (experimental)
Number of subjects: 32
Study 15346082 — intervention group
Group type: EXPERIMENTAL
Intervention: Both implants (LISS and distal femoral nail)
Number of subjects: 32
Study 12661145 — intervention group
Group type: COMPARATOR
Intervention: Maternal ET‐1 levels
Number of subjects: 0
Study 12661145 — intervention group
Group type: COMPARATOR
Intervention: Fetal ET‐1 levels
Number of subjects: 0